ETIVINC Trademark

Trademark Overview


On Monday, February 27, 2017, a trademark application was filed for ETIVINC with the United States Patent and Trademark Office. The USPTO has given the ETIVINC trademark a serial number of 87351062. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 3, 2024. This trademark is owned by Samsung Bioepis Co., Ltd.. The ETIVINC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
etivinc

General Information


Serial Number87351062
Word MarkETIVINC
Filing DateMonday, February 27, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 3, 2024
Registration Number5309874
Registration DateTuesday, October 17, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 3, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSamsung Bioepis Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIncheon
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIncheon
KR

Party NameSamsung Bioepis Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIncheon
KR

Trademark Events


Event DateEvent Description
Monday, May 22, 2017ASSIGNED TO EXAMINER
Thursday, March 2, 2017NEW APPLICATION ENTERED
Monday, March 6, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 8, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, March 8, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, March 8, 2017TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, May 24, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 1, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 1, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 17, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 3, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, May 24, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 24, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 24, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, May 24, 2017EXAMINERS AMENDMENT E-MAILED